Identification | More | [Name]
BOC-3-AMINOBENZOIC ACID | [CAS]
111331-82-9 | [Synonyms]
3-(BOC-AMINO)BENZOIC ACID 3-(TERT-BUTYLOXYCARBONYLAMINO)-BENZOIC ACID BOC-3-ABZ-OH BOC-3-AMINOBENZOIC ACID BOC-M-ABZ-OH H-ALPHA-T-BUTOXYCARBONYL-3-AMINOBENZOIC ACID N-ALPHA-T-BUTOXYCARBONYL-3-AMINOBENZOIC ACID N-ALPHA-T-BUTOXYCARBONYL-M-AMINOBENZOIC ACID 3-(T-BUTYLOXYCARBONYLAMINO)-BENZOIC ACID NALPHA-tert-Butoxycarbonyl-3-aminobenzoic acid | [Molecular Formula]
C12H15NO4 | [MDL Number]
MFCD00235884 | [Molecular Weight]
237.25 | [MOL File]
111331-82-9.mol |
Safety Data | Back Directory | [Safety Statements ]
S22:Do not breathe dust . S24/25:Avoid contact with skin and eyes . | [WGK Germany ]
3
| [HazardClass ]
IRRITANT | [HS Code ]
29242990 |
Hazard Information | Back Directory | [Chemical Properties]
Brown powder | [Uses]
Boc-3-Abz-OH, is an intermediate in the synthesis of various pharmaceutical compounds, including inhibitors, and therapeutic agents. It can also be used in the preparation of conformationally-constrained cyclic peptides with biarylamine linkers. | [reaction suitability]
reaction type: Boc solid-phase peptide synthesis | [Synthesis]
GENERAL METHOD: To a stirred solution of m-aminobenzoic acid (5.00 g, 36.5 mmol) and sodium hydroxide (1.56 g, 39.3 mmol) in a solvent mixture of 1:1 water/dioxane (60 mL) at 0 °C was slowly added di-tert-butyl dicarbonate (14.3 g, 65.4 mmol). The reaction mixture was continued to be stirred at 0 °C for 3 h, followed by slow warming to room temperature and stirring overnight. After completion of the reaction, the reaction mixture was extracted with ethyl acetate (60 mL) and the extraction was repeated once (60 mL). The organic phases were combined and neutralized with 1 M aqueous KHSO4 to pH ≈ 7. The organic layer was separated, washed with water (60 mL) and dried over anhydrous magnesium sulfate. The solvent was removed by concentration under reduced pressure to give 3-(N-Boc-amino)benzoic acid (7.53 g, 87% yield) as an off-white solid, which could be used in the next reaction without further purification. | [References]
[1] Journal of Medicinal Chemistry, 2001, vol. 44, # 3, p. 441 - 452 [2] Tetrahedron, 2012, vol. 68, # 6, p. 1790 - 1801 [3] Patent: US2014/194383, 2014, A1. Location in patent: Paragraph 0500; 0507-0508 [4] Chemical Communications, 2013, vol. 49, # 66, p. 7340 - 7342 [5] Bioorganic and Medicinal Chemistry, 2018, |
|
|